This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Randomized, double-blind, placebo controlled, multi-center clinical trials of the tolerability, safety and immunogenicity of the inactivated whole-virion concentrated purified vaccine against COVID-19, manufactured by FSBSI \"Chumakov FSC R\&D IBP RAS\", on adult volunteers aged 18-60\" (Clinical trials, phase I/II). Study purpose is to assess the tolerability, safety and immunogenicity of the inactivated whole-virion concentrated purified coronavirus vaccine sorbed on adult volunteers aged 18-60.
Epistemonikos ID: 93059d3dd5efdcd22f03346710b854ac44bf8cb0
First added on: Sep 17, 2021